Skip to main content
. 2021 Apr 22;12:638556. doi: 10.3389/fphar.2021.638556

FIGURE 3.

FIGURE 3

Effect of HDIVC on the time to negative nucleic acid load. The overall negative probability of nasopharyngeal swab (A) and stool (C) at admission between the HDIVC and control groups were compared and no significant difference was found. The time to negative nucleic acid was compared between HDIVC and control groups for nasopharyngeal swab (B), median [IQR], days, 14 [8, 21] vs 13 [7, 21], P = 0.79) and for stool (D), median [IQR], days, 12 [7, 17] vs 13 [10, 20], P = 0.12). HDIVC, high dose intravenous vitamin C; COVID-19, coronavirus disease 2019. IQR, interquartile range.